Both in Pharmaceuticals
Lyell Immunopharma vs Niagen Bioscience
Over the past year LYEL returned −35.7% and NAGE returned −70.2%; their daily moves had a correlation of 0.16.
LYEL −35.7% NAGE −70.2%Growth of $1, one year, split-adjusted
| Metric | LYEL | NAGE |
|---|---|---|
| Price | $9.63 | $2.95 |
| Market cap | $236.0M | $233.4M |
| Today | −1.13% | −1.01% |
| 1 month | −33.7% | −10.3% |
| 6 months | −50.1% | −31.1% |
| Year to date | −68.7% | −53.6% |
| 1 year | −24.9% | −69.8% |
| Revenue growth (YoY) | −50.0% | −4.3% |
| Gross margin | 100.0% | 64.8% |
| Net margin | −1118875.0% | 3.2% |
| P/E (TTM) | — | 14.6× |
| Price / sales | 8,740.2× | 1.8× |
| Net cash | $204.1M | $66.7M |
| Dividend yield | — | — |
| Volatility (60d) | 66.7% | 49.6% |
| Short % of float | 13.4% | 7.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).